ANI Pharmaceuticals
ANIP
#5013
Rank
C$2.51 B
Marketcap
C$110.60
Share price
3.65%
Change (1 day)
17.57%
Change (1 year)

EPS for ANI Pharmaceuticals (ANIP)

EPS in 2025 (TTM): C$2.38

According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$2.34. In 2024 the company made an earnings per share (EPS) of C-$1.53.

EPS history for ANI Pharmaceuticals from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$2.38-255.37%
2024C-$1.53
2022C-$4.16-6.46%
2021C-$4.4472.87%
2020C-$2.57-476%
2019C$0.68-62.12%
2018C$1.80
2015C$1.83-47.66%
2014C$3.50-142.11%
2013C-$8.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
C$9.84 321.05%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.86-20.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
C$9.55 308.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
C-$7.91-438.60%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
C-$3.44-247.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$5.32-327.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$1.69-27.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
C$2.40 2.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
C-$34.55-1,578.36%๐Ÿ‡บ๐Ÿ‡ธ USA